Businesses will want to borrow. Sadly this is because they got fat overextending and borrowing at low rates for years. That said, they will only borrow if the US figures out how to get their population healthy and not scared anymore. This means test kits, testing, and managing the sick. Until we can do this, all bets are off.

As for banks, it doesn't matter what the rate is. They will try to lend through whatever means the can to screw the consumer be it tying the lending to your home (they love your home and can resell the bonds to people who want to foreclose on you at the worst time possible), tying it to student loans so you can't escape debt enslavement by declaring bankruptcy, or giving you a credit card at ridiculously high rates. If you want to encourage growth, encourage companies that will issue credit cards at 10% or lower to people with good ratings and get companies to stop issuing high interest credit to people who can't handle it. the simple fact is zirp doesn't help the population as much as one would think. It merely widens the spread banks make charging customers for credit.

If we spend the $1-2 trillion stimulus to go to consumers and require it to go to debt payments only it would help Americans greatly and put them on more solid footing going forward.

The main promise is uncertainty as to when, how, and who will fix the medical crisis. In fact due to insufficient testing kits we don't even know how big the crisis is or if even you have the virus. Until that is taken care of, no one can predict revenue flow, profitability, or growth. Thus the market no matter how cheap becomes speculative. The market hates uncertainty and after weeks the Federal government has not dealt with any of the central problems or uncertainties.

Thus the crisis right now is not monetary. It is do completely to uncertainty that extends beyond monetary concerns that must be dealt with rapidly.

Uncertainty is destroying the market because there is still no coordinated response for testing kits, testing, ventilators and hazmat suits, and medical services to deal with this after weeks. In the meantime the found case numbers are doubling every week. Discussions about suppressing unemployment numbers is fuel to the fire. We need clarity and coordination more than anything else. The market is reacting to the unknown and lack of a central strategy to fix the epidemic. Without this talk of bailouts etc. mean nothing.

Without a strategy and timeline to fix the medical crisis things that are based on future income are uncertain at best and thus valuating them no matter what the bailout is, is pure speculation. The market hates uncertainty.

Actually, I'm surprised there are not more sales not that it will get people to shop that much more due to the virus.

It is funny people are so worried about drops in oil demand and not consumables and other things that are not critical to every day living like coffee, eating out, clothing, etc. These are the things that are and will continue to be slammed. People will still drive, just not go on cruise ships and big vacations.

Sadly the President is not a voice for calm, especially when he says people with the virus are going to work and nothing bad is happening so it's ok which is silly because this is coming from a germaphobe.

I doubt if Russia will cut more. They are trying support their weak economy and need to justify their pipeline plans to Asia as well as supply European nations they already upset by cutting supply to a few years back.

No. but it has clearly spread further into the population.

Because it is used for actual demand and due to shipping times implies real future expectation for goods. It is a issue of putting your money where your mouth is. Those shipping product have put money into the belief they will sell whereas consumer confidence is more theoretical.

This is from Wikipedia and can help for the time being. I think they don't use it much because of the side effects and risk to your eyes. It looks like it prevents the side effects so your body can heal than doing what they are talking about, an antidote. It looks like it can help the effects so your body can work more on killing the disease than dealing with lung inflammation.

Hydroxychloroquine increases lysosomal pH in antigen-presenting cells. In inflammatory conditions, it blocks toll-like receptors on plasmacytoid dendritic cells (PDCs). Hydroxychloroquine, by decreasing TLR signaling, reduces the activation of dendritic cells and the inflammatory process. Toll-like receptor 9 (TLR 9) recognizes DNA-containing immune complexes and leads to the production of interferon and causes the dendritic cells to mature and present antigen to T cells, therefore reducing anti-DNA auto-inflammatory process. A drug candidate developed by APEIRON Biologics named APN01 is being tested in China in a phase one pilot trial as a treatment for Covid-19. APN01 is based on research conducted by a professor at the University of British Columbia for treating SARS. The research revealed that the ACE2 protein was the main receptor for the SARS virus.

Moderna and the Vaccine Research Center, a unit of the National Institute of Allergy and Infectious Diseases (NIAID), have collaborated to develop a vaccine for coronavirus. The vaccine targets the Spike (S) protein of the coronavirus.

The MIGAL Research Institute in Israel announced that an Infectious Bronchitis Virus (IBV) vaccine developed to treat avian coronavirus has been modified to treat Covid-19. The vaccine has demonstrated efficacy in pre-clinical trials conducted by the Volcani Institute.

Clover Biopharmaceuticals is developing a recombinant subunit vaccine using its patented Trimer-Tag technology. The company is developing the vaccine based on the trimeric S protein (S-Trimer) of the Covid-19 coronavirus, which is responsible for binding with the host cell and causing a viral infection.

An ebola drug developed by Gilead Sciences that was found to be ineffective is now being tested in two phase III randomised clinical trials in Asian countries.

There are a lot more. See the following: http://www.clinicaltrialsarena.com.